Larvol Delta - Aisa-Pharma-Announces-Encouraging-Results-from-Phase-2-RECONNOITER-Trial-of-AISA021-Cilnidipine-in-Patients-with-Systemic-SclerosisAssociated-Raynauds-Phenomenon

Profervia (cilnidipine) - Aisa Pharma

Aisa Pharma Announces Encouraging Results from Phase 2 RECONNOITER Trial of AISA-021 (Cilnidipine) in Patients with Systemic Sclerosis-Associated Raynaud's Phenomenon

Mar 6, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next